Activated prothrombin concentrate for patients with factor VIII inhibitors.
D000293:Adolescent; D000328:Adult; D001778:Blood Coagulation Disorders / Q000097:blood / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D005164:Factor IX / Q000032:analysis / Q000627:therapeutic use; D005167:Factor VII / Q000032:analysis / Q000627:therapeutic use; D005169:Factor VIII / Q000037:antagonists & inhibitors*; D005170:Factor X / Q000032:analysis / Q000627:therapeutic use; D005172:Factor XI / Q000627:therapeutic use; D005260:Female; D006467:Hemophilia A / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011516:Prothrombin / Q000627:therapeutic use; D011517:Prothrombin Time
D001779:Blood Coagulation Factors; D004338:Drug Combinations; D005167:Factor VII; D011516:Prothrombin; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005172:Factor XI